Deep vein thrombosis and lung cancer in a patient with psoriasis under anti-tumor necrosis factor treatment: A case study

Dermatologic Therapy

Volumn 27, Issue 1, 2014, Pages 39-42

  Tatarkova, Iva ^a   Cetkovska, Petra ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

Author keywords

deep vein thrombosis; etanercept; lung cancer

Indexed keywords

COUMARIN DERIVATIVE; D DIMER; EFALIZUMAB; ETANERCEPT; ETRETIN; INSULIN; LOW MOLECULAR WEIGHT HEPARIN; METHOTREXATE; URIC ACID;

ADULT; BODY MASS; CANCER DIAGNOSIS; CASE REPORT; CASE STUDY; CAUCASIAN; CONFERENCE PAPER; DEEP VEIN THROMBOSIS; DISEASE SEVERITY; DOPPLER ECHOGRAPHY; DRUG WITHDRAWAL; HAIR LOSS; HIGH RESOLUTION COMPUTER TOMOGRAPHY; HISTOLOGY; HUMAN; HYPERTENSION; LEG SWELLING; LUNG SQUAMOUS CELL CARCINOMA; MALE; MEDICAL HISTORY; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PARTIAL THROMBOPLASTIN TIME; PHYSICAL EXAMINATION; PSORIASIS; RISK FACTOR; SMOKING; SMOKING CESSATION; THORAX RADIOGRAPHY; TREATMENT DURATION;

EID: 84893541344     PISSN: 13960296     EISSN: 15298019     Source Type: Journal    
DOI: 10.1111/dth.12041     Document Type: Conference Paper

References (17)

1. Nestle FO, Kaplan DH, Barker J,. Psoriasis. N Engl J Med 2009: 361: 496-509.
2. Menter A, Griffiths CE,. Current and future management of psoriasis. Lancet 2007: 370: 272-284.
3. Gerdes S, Rostami-Yazdi M, Mrowietz U,. Adipokines and psoriasis. Exp Dermatol 2011: 20: 81-87.
4. Makol A, Grover M, Guggenheim C, Hassouna H,. Etanercept and venous thromboembolism: a case series. J Med Case Rep 2010: 4: 12.
5. Mariette X, Matucci-Cerinic M, Pavelka K, et al. Malignancies associated with tumour necrosis factor inhibitors in registries and prospective observational studies: a systematic review and meta-analysis. Ann Rheum Dis 2011: 70: 1895-1904.
6. Boehncke WH, Boehncke S, Schön MP,. Managing comorbid disease in patients with psoriasis. BMJ 2010: 340: b5666.
7. Zhao Y, Chen G, Zhao R, Zhang X,. Psoriasis complicated with venous thromboembolism: report of two cases and literature review. Chin Med J (Engl) 2011: 124: 1593-1596.
8. Ahlehoff O, Gislason GH, Lindhardsen J, et al. Psoriasis carries an increased risk of venous thromboembolism: a Danish Nationwide Cohort Study. PLoS ONE 2011: 6: e18125.
9. Brauchli BY, Jick SS, Miret M, Meier ChR,. Psoriasis and risk of incident cancer: an inception cohort study with a nested case-control analysis. J Invest Dermatol 2009: 129: 2604-2612.
10. Skřičková J, Tomíšková M, Babičková L, Kaplanová J,. Diagnosis and treatment of lung cancer in elderly patients. Čes Ger Rev. 2011: 6: 20-30.
11. Dela Cruz CS, Tanoue LT, Matthay RA,. Lung cancer: epidemiology, etiology, and prevention. Clin Chest Med 2011: 32: 605-644.
12. Cataldo JK, Dubey S, Prochaska JJ,. Smoking cessation: an integral part of lung cancer treatment. Oncology 2010: 78: 289-301.
13. Helland A, Brustugun OT,. Lung cancer in smokers and never-smokers. Tidsskr Nor Laegeforen 2009: 129: 1859-1862.
14. Heinemann S, Zabel P, Hauber HP,. Paraneoplastic syndromes in lung cancer. Cancer Ther 2008: 6: 687-698.
15. Tesselaar ME, Osanto S,. Risk of venous thromboembolism in lung cancer. Curr Opin Pulm Med 2007: 13: 362-367.
16. Leeds CH, Ironside J, Wallace WAH, Satsangi J,. Resolution of non-small-cell lung cancer after withdrawal of anti-TNF therapy. N Engl J Med 2008: 359: 320-321.
17. Strober B, Berger E, Cather J, et al. A series of critically challenging case scenarios in moderate to severe psoriasis: a Delphi consensus approach. J Am Acad Dermatol 2009: 61: S1-S46.